Parvovirus B19 infection associated with myelosuppression and cutaneous polyarteritis nodosa [13]

Rheumatology

Volumn 41, Issue 10, 2002, Pages 1210-1212

  Durst, R ^a   Goldschmidt, N ^a   Ben Yehuda, A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ADULT; ANEMIA; BLOOD TRANSFUSION; BONE MARROW SUPPRESSION; CANADA; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DEATH; DIABETES MELLITUS; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ERYTHEMA INFECTIOSUM; FATIGUE; FEVER; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; ISRAEL; LETTER; MALE; MEDICAL ASSESSMENT; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PARVOVIRUS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RASH; SEROLOGY; TRAVEL; UNITED STATES;

AGED; BONE MARROW CELLS; HUMANS; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYARTERITIS NODOSA;

EID: 0036796778     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. Garcia-Tapia AM, Fernandez-Gutierrez del Alamo C, Giron JA et al. Spectrum of parvovirus B19 infection: Analysis of an outbreak of 43 cases in Cadiz, Spain. Clin Infect Dis 1995;21:1424-30.
2. Nikkari S, Mertsola J, Kovernata H, Vainiopaa R, Toinavanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994;37:1707-8.
3. Corman LC, Stand R. Association of Wegener's granulomatosis with parvovirus B19 infection [comment]. Arthritis Rheum 1995;38:1174-5.
4. Corman LC, Dolson DJ. Parvovirus B19 and necrotizing vasculitis [abstract]. Arthritis Rheum 1992;35(Suppl. 9):S165.
5. Corman LC, Dolson DJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992;339:491.
6. Finkel TH, Torok TJ, Ferguson PJ et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or etiological agent? Lancet 1994;343:1255-8.
7. Zulian F, Costantini C, Montesco MC, Shiavon F, Zacchello F. Successful treatment of gangrene in systemic necrotizing vasculitis with Iloprost. Br J Rheumatol 1998;37:228-30.
8. Viguier M, Guillevin L, Laroche L. Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin. N Engl J Med 2001;344:1481-2.
9. Gaches F, Loustaud V, Vidal E et al. Périartérite noueuse et infection par le parvovirus B19. Rev Med Intern 1993;14:323-5.
10. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B 19 in England and Wales. J Med Microbiol 1988; 25:151-3.
11. Pirayesh A, Verbunt RJ, Kluin PM et al. Myelodysplastic syndrome with vasculitic manifestation. J Intern Med 1997;242:425-31.
12. Brickner LA, Scannell KA. Medium vessel PAN-type vasculitis associated with myelodysplastic syndrome. Clin Exp Rheumatol 1997;15:221-2.
13. Tyndall A, Jelk W, Hirsch HH. Parvovirus B19 and erosive polyarthritis. Lancet 1993;19:457.
14. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998;7:238-58.
15. Habib G, Cohen L. Many faces of parvovirus. Harefuah 1999; 136:936-7.
16. Anderson LJ, Tsou C, Parker RA et al. Detection of antibodies and antigen of human parvovirus B19 by enzyme linked immunosorbent assay. J Clin Microbiol 1986;24:522-6.